Disease correction in mucopolysaccharidosis type IIIB mice by intraparenchymal or cisternal delivery of a capsid modified AAV8 codon-optimized NAGLU vector is a research paper published in Human Molecular Genetics (2022). On theSindex it has a DataRank of 0. It has been cited 9 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Neurological Disorders and Stroke
Grant: R01NS102624
National Institute on Deafness and Communication Disorders
Grant: R01 DK067859
National Institute on Deafness and Communication Disorders
Grant: R03 DC011840
National Institute on Deafness and Communication Disorders
Grant: R01 DC012552
National Institute on Deafness and Communication Disorders
Grant: R01 DC014437
National Institutes of Health
National Institute of Neurologic Disorders and Stroke
National Institute on Diabetes, Digestive and Kidney Disease
MeSH Terms
Additional file 1 of Systematic gene therapy derived from an investigative study of AAV2/8 vector gene therapy for Fabry disease
Additional file 1 of Systematic gene therapy derived from an investigative study of AAV2/8 vector gene therapy for Fabry disease